BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 28682067)

  • 1. Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.
    Luo M; Groaz E; Andrei G; Snoeck R; Kalkeri R; Ptak RG; Hartman T; Buckheit RW; Schols D; De Jonghe S; Herdewijn P
    J Med Chem; 2017 Jul; 60(14):6220-6238. PubMed ID: 28682067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Anti-HIV Activity of Guanine Modified Fluorinated Acyclic Nucleoside Phosphonate Derivatives.
    Luo M; Groaz E; De Jonghe S; Schols D; Herdewijn P
    Chem Biodivers; 2019 Feb; 16(2):e1800532. PubMed ID: 30431702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
    Krecmerova M
    Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus.
    Baszczyňski O; Kaiser MM; Česnek M; Břehová P; Jansa P; Procházková E; Dračínský M; Snoeck R; Andrei G; Janeba Z
    Antivir Chem Chemother; 2018; 26():2040206618813050. PubMed ID: 30497281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity.
    Krečmerová M; Dračínský M; Snoeck R; Balzarini J; Pomeisl K; Andrei G
    Bioorg Med Chem; 2017 Sep; 25(17):4637-4648. PubMed ID: 28757102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.
    Liu C; Dumbre SG; Pannecouque C; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
    J Med Chem; 2016 Oct; 59(20):9513-9531. PubMed ID: 27748590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
    Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
    Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.
    Valiaeva N; Wyles DL; Schooley RT; Hwu JB; Beadle JR; Prichard MN; Hostetler KY
    Bioorg Med Chem; 2011 Aug; 19(15):4616-25. PubMed ID: 21719300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkoxyalkyl esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.
    Hostetler KY; Aldern KA; Wan WB; Ciesla SL; Beadle JR
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2857-9. PubMed ID: 16870786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
    Kaiser MM; Poštová-Slavětínská L; Dračínský M; Lee YJ; Tian Y; Janeba Z
    Eur J Med Chem; 2016 Jan; 108():374-380. PubMed ID: 26706348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
    Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
    J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of LAVR-289, a new [(Z)-3-(acetoxymethyl)-4-(2,4-diaminopyrimidin-6-yl)oxy-but-2-enyl]phosphonic acid prodrug with pronounced antiviral activity against DNA viruses.
    Bessières M; Roy V; Abuduani T; Favetta P; Snoeck R; Andrei G; Moffat J; Gallardo F; Agrofoglio LA
    Eur J Med Chem; 2024 May; 271():116412. PubMed ID: 38643669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors.
    Lu P; Liu J; Wang Y; Chen X; Yang Y; Ji R
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6918-21. PubMed ID: 19889538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity.
    Holý A; Votruba I; Masojídková M; Andrei G; Snoeck R; Naesens L; De Clercq E; Balzarini J
    J Med Chem; 2002 Apr; 45(9):1918-29. PubMed ID: 11960502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
    Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J
    J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities.
    Ying C; Holy A; Hocková D; Havlas Z; De Clercq E; Neyts J
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1177-80. PubMed ID: 15728921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy.
    Pertusati F; Serafini S; Albadry N; Snoeck R; Andrei G
    Antiviral Res; 2017 Jul; 143():262-268. PubMed ID: 28454912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.
    Fu X; Jiang S; Li C; Xin J; Yang Y; Ji R
    Bioorg Med Chem Lett; 2007 Jan; 17(2):465-70. PubMed ID: 17074481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
    Fu XZ; Jiang SH; Yang YS; Ji RY
    Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.